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Abstract 18	  
Salmonella effector protein SseJ is secreted by Salmonella into the host cell 19	  
cytoplasm where it can then modify host cell processes. Whilst host cell small 20	  
GTPase RhoA has previously been shown to activate the acyl-transferase 21	  
activity of SseJ we show here an un-described effect of SseJ protein 22	  
production upon microtubule dynamism. SseJ prevents microtubule collapse 23	  
and this is independent of SseJ’s acyl-transferase activity. We speculate that 24	  
the effects of SseJ on microtubules would be mediated via its known 25	  
interactions with the small GTPases of the Rho family.  26	  
Introduction 27	  
 Salmonellae are gram-negative bacteria that can infect a wide range of 28	  
hosts and in humans can cause diseases such as typhoid fever and 29	  
gastroenteritis. There are ~2600 recognized Salmonella serovars of which 30	  
over half are represented by S. enterica subspecies enterica (S. enterica 31	  
subspecies I), constituting 99% of human 32	  
clinical Salmonella infections. Salmonella enterica serovar Typhimurium (S. 33	  
Typhimurium; the cause of gastroenteritis) uses two type III secretion systems 34	  
(T3SS) to translocate pathogen effector proteins directly into the host cell’s 35	  
cytoplasm. (reviewed by [1]). The T3SS encoded by Salmonella pathogenicity 36	  
island-1 (SPI-1; T3SS-1) is mostly active when extracellular Salmonella come 37	  
into contact with a host cell and allows effector proteins to be translocated 38	  
directly into the cell cytoplasm and causes the bacteria to be actively 39	  
phagocytosed. Another T3SS encoded by Salmonella pathogenicity island-2 40	  
(SPI-2; T3SS-2) enables the bacteria to multiply intracellularly in a Salmonella 41	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containing vacuole (SCV) by allowing further effector proteins to be 42	  
translocated directly from the Salmonella (through the phagosomal 43	  
membrane) into the host cell cytoplasm. It is unclear precisely how 44	  
Salmonella uses its multiple T3SS effector proteins to survive intracellularly 45	  
but theories range from delaying fusion with the degradative organelle the 46	  
lysosome [2], though the role of the T3SS in this process is contested [3], to 47	  
preventing the delivery of lysosomal hydrolases to the Salmonella-containing 48	  
phagosomal compartment by altering mannose 6-phosphate receptor 49	  
trafficking [4]. Only a finite number of intracellular membrane trafficking and 50	  
signalling events can be manipulated by a pathogen and hence successful 51	  
intracellular pathogens are often found to target the same host cell molecules, 52	  
for instance phosphoinositides are targeted by both Salmonellae and 53	  
Mycobacteria [5, 6]. Understanding how Salmonella survives intracellularly not 54	  
only provides information about Salmonella pathogenesis but potentially what 55	  
processes may also be targeted by other intracellular pathogens. 56	  
 To understand the role of Salmonella T3SS effector proteins in the flow 57	  
of membranes to the lysosome a rapid screen was undertaken in 58	  
Saccharomyces cerevisiae (S. cerevisiae).  Membrane trafficking events are 59	  
conserved between yeast and mammalian cells. Therefore, yeast can be used 60	  
to rapidly identify any Sallmonella proteins that alter membrane traffic to the 61	  
yeast vacuole, the equivalent of the mammalian lysosome. The screen 62	  
identified the Salmonella virulence protein SseJ and subsequently we show a 63	  
previously un-described effect of this protein on the stability of host cell 64	  
microtubules. Microtubules are required for phagosome fusion [7-9] and by 65	  
promoting a network of stable microtubules this can aid in phagosome fusion 66	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with endocytic organelles enabling nutrients to be delivered to the 67	  
phagosomal lumen, promoting bacterial replication. 68	  
 69	  
Results 70	  
SseJ production causes membrane trafficking defects 71	  
To identify Salmonella proteins that can disrupt intracellular membrane 72	  
trafficking, a genomic library from Salmonella was generated and the DNA 73	  
inserted into a yeast expression vector. S. cerevisiae were then transformed 74	  
with the plasmid library and colonies screened for a defect in the delivery of 75	  
the vacuolar hydrolase, carboxypeptidase-Y (CPY), to the yeast vacuole. If 76	  
there is disruption of CPY delivery to the vacuole then CPY is secreted. We 77	  
assayed the secretion of a CPY-invertase fusion protein that oxidises an 78	  
applied solution of o-diansidine to a brown precipitate [10]. This approach has 79	  
been successfully employed to identify effector proteins of Legionella 80	  
pneumophila [11] and Mycobacterium tuberculosis [12] that interfere with 81	  
yeast membrane trafficking. Yeast transformed with the plasmid library were 82	  
screened for CPY-Inv secretion and 8 yeast clones were found to have CPY-83	  
Inv secretion in a plasmid dependent manner. One of the clones identified a 84	  
6kb fragment of Salmonella chromosomal DNA containing 1 partial open 85	  
reading frame (ORF) and 6 complete ORFs (Fig 1A). All of the Salmonella 86	  
genes identified in the plasmid, were cloned and expressed individually in 87	  
yeast and re-assayed for CPY secretion. Qualitative CPY-Inv secretion on 88	  
agar plates showed that SseJ caused CPY secretion, though we did not 89	  
analyse the protein production levels of the other 5 proteins. (Fig. 1B). 90	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Quantitative CPY-Inv secretion from yeast in liquid culture demonstrated that 91	  
SseJ dependent CPY-Inv secretion was equivalent to that in yeast lacking the 92	  
CPY receptor, VPS10 (∆VPS10; fig. 1C). There are numerous intermediate 93	  
vesicles involved in delivery of CPY to the vacuole and the retrograde 94	  
trafficking of the VPS10 receptor. When CPY is secreted, due to a trafficking 95	  
defect, it is possible to examine the phenotype of the yeast vacuole and in 96	  
some cases determine which part of the trafficking step of CPY from the Golgi 97	  
to the vacuole is disrupted [13, 14]. Using the membrane dye FM4-64 to label 98	  
the yeast vacuole in yeast expressing SseJ, no differences in the morphology 99	  
of the vacuole were seen compared to wild-type yeast (fig. 1D). These data 100	  
indicated that SseJ alone can cause a membrane trafficking defect in yeast. 101	  
SseJ production re-distributes late endocytic organelles 102	  
SseJ is one of several virulence proteins secreted by Salmonella’s T3SSs into 103	  
the host’s cytoplasm directly from the bacteria [15]. Salmonella strains lacking 104	  
SseJ are attenuated in replication [16-19] indicating that SseJ is crucial for 105	  
bacterial intracellular replication. SseJ was then expressed in mammalian 106	  
cells. In this case, we used Normal Rat Kidney (NRK) cells since they show 107	  
good spatial resolution between endocytic vesicles and in particular between 108	  
late endosomes and lysosomes. Late-endocytic organelles are poorly 109	  
resolved by light microscopy in HeLa cells, which are often used for 110	  
Salmonella infection studies. Constitutive protein production of SseJ was 111	  
found to cause cell death so myc-tagged SseJ (myc-SseJ) was expressed 112	  
under the control of a metallothionein promoter allowing for inducible sseJ 113	  
expression upon the addition of cadmium. Immunofluorescence demonstrated 114	  
that myc-SseJ localises to lysosomes (Fig. 2A) as has previously been 115	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reported [19]). Moreover there was a dramatic re-distribution of late endocytic 116	  
organelles with both late endosomes and lysosomes becoming less peri-117	  
nuclear and more peripherally distributed (Fig. 2B). The trans-Golgi marker 118	  
TGN38 was observed to occupy a larger area of the cell (Fig. 2B), but in 119	  
general cells were flatter with an increased surface area (on average the cell 120	  
surface area went from 591µm2 to 2,057µm2 upon SseJ expression). Ectopic 121	  
SseJ protein production can cause globular membranous compartments 122	  
(GMCs) [19] and indeed when sseJ expression was induced for 24 h, 123	  
lysosomes were seen to aggregate as observed by LGP120 (rat equivalent of 124	  
LAMP1) staining (Fig. 2C). The metallothionein promoter regulating sseJ 125	  
expression is slightly leaky due to the presence of trace amounts of heavy 126	  
metals in the tissue culture media, which explains why the lysosomes are 127	  
partially aggregated in transfected cells before cadmium addition (Fig. 2C 128	  
panel b). The re-distribution of organelles is observed when the cytoskeleton 129	  
is perturbed [20] and indeed when the microtubule polymerisation inhibitor 130	  
nocodazole was added to cells, late endocytic organelles re-distributed in a 131	  
manner similar to that observed with SseJ expression (Fig. 2D). 132	  
SseJ alters microtubule dynamics  133	  
To assess whether the re-distribution of organelles was related to changes to 134	  
the cytoskeleton the microtubules were visualised in cells expressing SseJ or 135	  
a mutant SseJ (SseJ S151A). SseJ has homology to the GDSL-like lipolytic 136	  
enzyme family [21] and shows deacylase, phospholipase and 137	  
glycerophospholipid-cholesterol acyltransferase (GCAT) activity [22-24]. 138	  
Ser151 in SseJ is the middle serine in a GDSLS motif, which is present in 139	  
GCAT enzymes and mutation of this residue reduces SseJ’s deacylase 140	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activity by 5 fold [22]. SseJ-S151A still localises to the Salmonella containing 141	  
vacuole and Salmonella induced filaments (Sifs) [25] are still visible in a SseJ-142	  
S151A mutant strain but the bacteria show reduced virulence [22]. The 143	  
microtubules, in both WT and mutant-SseJ expressing cells, became 144	  
disorganised with no clear microtubule organising centre (MTOC; Fig. 3A). In 145	  
J774.2 macrophages the majority of cells don’t have clear microtubules 146	  
emanating from a MTOC unless they have flattened out on the culture vessel 147	  
surface (Fig. 3B). Co-cultures of bacteria and J774.2 macrophages causes 148	  
the macrophages to flatten out and under these conditions the microtubule 149	  
network becomes more visible. However, a loss of organised microtubules, 150	  
emanating from a clearly defined MTOC, was seen in mouse macrophages 151	  
infected with WT Salmonella but not in cells infected with ∆sseJ Salmonella 152	  
(Fig. 3B). Typically, ∆sseJ Salmonella induced a four-fold increase in visible 153	  
microtubules emanating from the MTOC compared to control cells, but WT 154	  
Salmonella only induced a two-fold increase (Fig. 3B). Unlike nocodazole that 155	  
completely disrupts tubulin polymers (Fig. 2D), cells expressing SseJ still 156	  
show some tubulin polymers albeit in a dis-organised manner. Long-lived, 157	  
stable microtubules are de-tyrosinated, resulting in the exposure of a 158	  
glutamate residue (Glu-tubulin), and acetylated [26, 27]. Cells were then 159	  
examined for the presence of Glu-tubulin (Fig. 3C). In cells expressing both 160	  
WT and mutant SseJ protein there was a reduction in Glu-tubulin 161	  
immunolabelling compared to control cells. Furthermore, there was a 162	  
reduction in acetylated-tubulin (Fig. 3D) in WT and mutant sseJ expressing 163	  
cells. The reduction in acetylated-tubulin corresponded to the time of induction 164	  
of sseJ expression (Fig. 3E). SseJ protein production was induced with 10µM 165	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cadmium and the metal can alter the cytoskeleton [28, 29] but we saw no 166	  
effect of cadmium on the cytoskeleton in NRK cells without ssej expression 167	  
(all control cells in figure 3 are in the presence of 10µM cadmium chloride). 168	  
Together these data suggested that long-lived microtubules had been de-169	  
stabilised in cells expressing SseJ, but some un-organised microtubules could 170	  
still be observed. When cells were transfected with a plasmid encoding GFP-171	  
CLIP-170, a protein that binds to the growing ends of microtubules, and 172	  
visualised by live cell microscopy, no CLIP-170 movement could be observed 173	  
in cells expressing SseJ (supplemental movie) compared to control cells 174	  
(supplemental movie). Similar data were obtained with EB3-tdTomato, 175	  
another microtubule plus-end binding protein, and single images of EB3-176	  
tdTomato transfected cells show the EB3 on the end of microtubules in control 177	  
cells but no visible incorporation of the EB3 onto microtubules in cells 178	  
expressing SseJ (Fig 3F). So whilst there was a reduction in long-lived 179	  
microtubules, as assessed by Glu-tubulin and acetylated-tubulin, there was no 180	  
dynamism in the remaining microtubules.  181	  
SseJ binds both RhoA and RhoC 182	  
Rho proteins are small GTPases that are primarily associated with modifying 183	  
the actin cytoskeleton, but they can effect cell polarity and microtubules [30]. 184	  
SseJ can interact with both RhoA or RhoC [31, 32], with GTP-bound RhoA 185	  
activating SseJ’s lipase activity [32]. SseJ has only previously been shown to 186	  
bind RhoA or RhoC separately. Large scale immunoprecipitations of SseJ 187	  
from cells overexpressing SseJ identified both RhoA and RhoC having bound 188	  
to SseJ under experimental conditions where the GTPases were in their GDP-189	  
bound form (Fig. 4A), with WT and SseJ-S151A binding Rho proteins with 190	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equal ability (Fig. 4B). These experiments indicate that SseJ can bind either 191	  
RhoA or RhoC in the presence of each other when neither protein is in a 192	  
limiting amount. Although we have no evidence, it is unlikely that SseJ is 193	  
binding both RhoA and RhoC simultaneously. Using an ELISA we found, as 194	  
has been reported [32], that SseJ did not increase the levels of activated 195	  
(GTP-bound) RhoA (Fig. 4C). 196	  
Discussion 197	  
In this study, we aimed to understand how Salmonella can survive 198	  
intracellularly by uncovering Salmonella effector molecules that can 199	  
manipulate membrane trafficking events. Manipulation of membrane traffic 200	  
may disrupt late-organelle biogenesis, including lysosomes, and therefore 201	  
provide conditions that enable the bacteria to replicate. We hypothesised that 202	  
a Salmonella T3SS effector molecule may manipulate membrane trafficking in 203	  
yeast to the same extent as mammalian cells given that the delivery of 204	  
molecules to the vacuole/lysosome are conserved. Using an unbiased screen 205	  
we identified SseJ, which is a T3SS effector protein, that caused a membrane 206	  
trafficking defect in yeast (Fig. 1). This is the first demonstration that SseJ 207	  
causes changes to membrane trafficking in eukaryotes. The powerful yeast 208	  
screen led us to examine the distribution of organelles in mammalian cells, 209	  
expecting them to be perturbed. Indeed, organelles no longer localised to the 210	  
MTOC (Fig. 2) and this observation could be related to changes to the 211	  
microtubules (Fig. 3). We further showed that SseJ can bind to both RhoA 212	  
and RhoC and whilst others have shown that RhoA can regulate the GCAT 213	  
activity of SseJ [32] this is the first report to prove the hypothesis that SseJ 214	  
alters the cytoskeleton [33].  215	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 How might SseJ alter the cytoskeleton? Whilst Rho proteins are well 216	  
known to alter the actin cytoskeleton they can also alter the stability of 217	  
microtubules via Diaphanous-related formins (DRFs) [34]. RhoA-mDia1/2 can 218	  
stimulate microtubule stabilisation with an increase in Glu-tubulin, precisely 219	  
how this is achieved is unknown, and it is possible that if SseJ recruits active 220	  
Rho proteins to the lysosome then the RhoA-mDia1/2 balance may be 221	  
disrupted leading to changes in the microtubules. Whilst we did not observe 222	  
an increase in Glu-tubulin we did see static microtubules. Although the 223	  
binding of SseJ to RhoA or RhoC has been documented, our data show for 224	  
the first time that SseJ can bind RhoA or RhoC when both proteins are 225	  
present and neither are in limited amounts i.e. SseJ does not preferentially 226	  
bind RhoA and then RhoC (Fig 4). This does raise the possibility that SseJ 227	  
may have differential effects through both RhoA and RhoC, with differences 228	  
between RhoA, RhoB and RhoC well documented [35]. So whilst RhoA-GTP 229	  
can stimulate the GCAT activity of SseJ [32], the binding of RhoC to SseJ 230	  
may affect the microtubules. RhoC is reported to have a higher affinity for the 231	  
kinases Rho-associated coiled-coil containing kinases (ROCK) and Citron 232	  
kinase compared to RhoA [35]. MAP2/Tau proteins stabilise microtubules and 233	  
inhibit depolymerisation (reviewed by [36]), an effect seen in SseJ expressing 234	  
cells, and MAP2/Tau proteins can be phosphorylated by numerous kinases 235	  
including ROCK [35, 37]. The effects of MAP2/Tau phosphorylation are yet to 236	  
be determined, but there is a precedence for microtubule regulation by Rho 237	  
proteins via DRFs and kinases such as ROCK [38]. Expression of sseJ before 238	  
Salmonella infection reduces Sif formation [19], which can be explained by the 239	  
fact that a dynamic cytoskeleton is required for phagosome maturation [39]. 240	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Additionally, whereas SseJ-S151A has reduced GCAT activity [22] the effects 241	  
on the microtubules are still seen in the S151A mutant suggesting that the 242	  
GCAT activity is separate from the microtubule effect, though we can’t rule out 243	  
that there is still enough residual GCAT activity in cells over-expressing sseJ. 244	  
 SseJ has been shown to interact indirectly with another T3SS effector 245	  
protein, SifA [31]. ∆sifA mutants escape the phagosomal vacuole but not if a 246	  
double sifA sseJ mutant is made, implying that loss of the integrity of the 247	  
phagosomal membrane is dependent on SseJ [19]. SifA and SseJ are 248	  
sufficient to cause endosome tubulation [31] and certainly SifA is required for 249	  
endosome tubulation [40, 41]. With SifA found to bind to RhoA, and SKIP, 250	  
which is a kinesin binding protein, it was hypothesised that RhoA, SseJ, SifA 251	  
and SKIP regulates endosome tubulation along microtubules [31]. However, 252	  
studies have shown that ∆sseJ Salmonella show endosomal tubulation 253	  
implying that SseJ is dispensable for endosome tubulation in a background 254	  
where all the other secreted effector proteins are expressed [42, 43]. 255	  
 Salmonella induced endosomal tubules or Salmonella induced 256	  
filaments (Sifs) are initially dynamic but become stabilised (>8h after cell 257	  
infection; [42] and this stabilisation could correspond to the changes that we 258	  
see in the dynamics of the microtubules, given that  SseJ is secreted from 259	  
Salmonella within 4 h [17]. It is has been known for a long time that 260	  
lysosomes can form tubules [44, 45] and that microtubules regulate the 261	  
distribution of lysosomes [46] and their tubular morphology [7]. Although SseJ 262	  
is dispensable for the formation of Sifs in infected cells, SseJ may aid in 263	  
stabilising the Sifs that do form.. Why would this be advantageous to the 264	  
Salmonella? Endosome fusion and delivery of endocytosed material to 265	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lysosomes can occur at the end of lysosome tubules [47] and the curvature of 266	  
the membrane at the tip of a tubule is likely to be more fusogenic with 267	  
endocytic vesicles compared to a larger, more-rounded phagosomal 268	  
membrane [48]. By reducing microtubule de-polymerisation this allows 269	  
Salmonella to promote tubular lysosomes (endosomal tubules), in conjunction 270	  
with other proteins such as SifA, increasing fusion events with endosomal 271	  
vesicles carrying in nutrients from the extracellular environment. Rho 272	  
GTPases are a common target of bacterial pathogens [49, 50] and further 273	  
work is required to determine whether SseJ’s effect on cellular microtubules is 274	  
mediated through RhoA or RhoC. 275	  
Materials and Methods 276	  
Reagents and Antibodies 277	  
Chemical reagents were of laboratory grade. Anti-c-myc (9E10) antibodies 278	  
were purified from 9E10 hybridoma tissue culture supernatants 279	  
(Developmental Studies Hybridoma Bank). Anti rat LGP110 (580), anti-mouse 280	  
cation-independent mannose 6-phosphate receptor (MPR; 1001) and anti-rat 281	  
TGN38 (2F7.1) were kind gifts from J. P. Luzio (University of Cambridge, UK). 282	  
Anti α-tubulin (T-9026) was from Sigma, anti-glu-tubulin was from Synaptic 283	  
Systems, anti-acetylated tubulin (D20G3), rabbit monoclonal anti-RhoA 284	  
(67B9) and anti-RhoC (D40E4) were from Cell Signalling. 285	  
Yeast Strains 286	  
BHY10 and BHY11 haploid yeast strains expressing CPY-Inv [51] and BHY10 287	  
ΔVPS10::TRP1 were a kind gift from Dr. M. Seaman (University of 288	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Cambridge). For the screen BHY10 and BHY11 were mated on YPD agar 289	  
plates, diploid yeast (BHY12) picked from SC–Lys,-Ade plates and then 290	  
maintained on YPD agar plates.  291	  
Salmonella genomic library generation  292	  
Chromosomal DNA was isolated from stationary phase Salmonella 293	  
Typhimurium strain 14028 [52]. DNA was partially digested with Sau3AI for 1h 294	  
at 37°C. DNA was electrophoresed on a gel, and the region corresponding to 295	  
≈0.8-5 kb was excised and the DNA purified. pVT-100 U [53] a gift from Dr. K. 296	  
Bowers (UCL, UK), was linearised with BamHI and then de-phosphorylated 297	  
using calf intestinal phosphatase. DNA was ligated into linearised pVT-100U 298	  
using T4 DNA ligase and transformed into NEB 10-beta competent E. 299	  
coli (High Efficiency). Ampicillin-resistant colonies (≈0.5x106) were scraped, 300	  
and plasmid DNA prepared (Qiagen midiprep).  301	  
Constructs 302	  
SseJ was cloned from S. Typhimurium DNA by PCR. Primers were used to 303	  
append a myc-tag to the SseJ PCR product along with 15bp regions of 304	  
homology to the destination vector to allow for homologous recombination 305	  
using In-Fusion cloning (Invitrogen). The myc-tagged SseJ DNA was inserted 306	  
into the HindIII restriction enzyme site of the ∆pMEP4 vector [54] by 307	  
homologous recombination. The S151A mutant was made by QuikChange 308	  
site-directed mutagenesis (Stratagene) of the myc-SseJ construct as per the 309	  
manufacturer’s instructions. 310	  
 311	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Invertase (Inv) assays 312	  
The Salmonella plasmid library was transformed into BHY12 yeast [55], and 313	  
transformants were plated on synthetic complete medium without uracil (SC-314	  
Ura) plates with 2% (w/v) fructose. Carboxypeptidase-Y-invertase (CPY-Inv) 315	  
assay, both quantitatively and qualitatively, is based on previous 316	  
methodologies [10].  317	  
FM4-64 Staining  318	  
1ml of log-phase yeast were pelleted and then resuspended in 50µl YPD 319	  
medium containing 40µM FM 4-64 (Molecular Probes). Yeast were incubated 320	  
at 30ºC for 15 min before the yeast were pelleted and washed with YPD 321	  
media. Yeast in fresh YPD were then incubated for 30 min at 30ºC. Yeast 322	  
were pelleted and then resuspended in 1ml of H20 and then aliquots directly 323	  
visualised by confocal microscopy. 324	  
Tissue culture and cell transfection 325	  
All cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM), 326	  
supplemented with 10% (v/v) FCS, 100U/L penicillin, 100mg/L streptomycin 327	  
and 2mM L-glutamine, in a humidified atmosphere with 5% CO2. Cells were 328	  
transfected with plasmid DNA using Fugene 6 (Roche Diagnostics) as per the 329	  
manufacturer’s instructions. ∆pMEP4 transfected cells were selected with 330	  
media containing 0.2 mg/ml hygromycin to generate a stable population of 331	  
transfected cells and individual clones were selected and assessed for SseJ 332	  
protein production. SseJ production was induced with 10 µM CdCl2 for 16-24h 333	  
before analyses. 334	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J774.2 Salmonella infection. 335	  
J774.2 cells were seeded onto glass coverslips and cultured for 48 h in 336	  
antibiotic-free DMEM medium supplemented with 10 % (v/v) FBS (heat 337	  
inactivated to 56 ºC for 30 min) and 2 mM glutamine. Salmonellae (WT and 338	  
∆SseJ Salmonella enterica serovar Typhimurium strain 12023 were a kind gift 339	  
from Prof. David Holden, Imperial College London). were cultured overnight in 340	  
LB media with shaking at 30 ºC. An appropriate number of bacteria were 341	  
taken to infect J774.2 cells at an MOI (multiplicity of infection) of 10 and 342	  
resuspended in PBS. Bacteria were centrifuged onto cells at 80 x g for 5 min 343	  
and incubated for 1 h at 37 ºC to allow phagocytosis of bacteria. Monolayers 344	  
were rinsed 3 times with DMEM to remove unbound bacteria, and the media 345	  
replaced with DMEM containing 150 µg/ml gentamycin to kill extracellular 346	  
bacteria. The cells were cultured for a further hour, and washed with PBS. 347	  
The media was then replaced with DMEM containing 10 µg/ml gentamycin, 348	  
and cells cultured for 24 h to allow intracellular bacteria to grow. Cells were 349	  
fixed with 4 % formaldehyde in PBS for 20 min at room temperature and then 350	  
processed for immunofluorescence.  351	  
Immunofluorescence 352	  
Cells were fixed with 4 % (w/v) formaldehyde in PBS for 20 min at 20ºC. Cells 353	  
to be immunolabelled for microtubules were rinsed with microtubule stabilising 354	  
buffer (MTSB; 80mM PIPES, pH 6.8, 1mM MgCl2, 4mM EGTA) then 355	  
incubated in MTSB containing 0.05% (w/v) saponin (Sigma S-4521) for 1 min 356	  
then fixed with 2% (w/v) formaldehyde, 0.05% (w/v) glutaldehyde in MTSB for 357	  
20 min. Cells immunolabelled for Glu-tubulin were fixed with -20ºC MeOH for 358	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5 min at -20ºC. All fixed cells were incubated for 10 min in 50 mM NH4Cl in 359	  
PBS followed by 10 min in 0.2 % (w/v) BSA in PBS containing 0.5% (w/v) 360	  
saponin (PBS-BS). Cells were immunolabelled with primary antibodies in 361	  
PBS-BS for 1h at 20ºC. Cells were rinsed 3 x 5 min with PBS-BS and then 362	  
incubated with fluorescent secondary-antibodies in PBS-BS for 30 min at 363	  
20ºC. Cells were rinsed 3 x 5 min with PBS-BS before being mounted in 364	  
Mowiol. Fluorescence was imaged using a Zeiss LSM510 confocal 365	  
microscope. All images are maximum intensity z-projections unless otherwise 366	  
stated. 367	  
Cell lysates 368	  
Lysates were generated by rinsing cells with PBS and then scraping cells into 369	  
ice cold lysis buffer (150 mM NaCl, 20 mM Tris, pH 8.0, 2 mM EDTA, 0.5 % 370	  
(v/v) NP-40). Lysates were left on ice for 10 min before removal of detergent 371	  
insoluble material by centrifugation (16,400 g, 10 min, 4ºC). 372	  
Immunoprecipitation 373	  
9E10 antibody was coupled to Amino Link Plus resin (Pierce) following the 374	  
manufacturer’s instructions. Small scale immunoprecipitations used 20 µl of 375	  
resin and 250µg of cell lysate and samples were incubated for 2 h at 4ºC with 376	  
rotation. Resins were washed 3 x with lysis buffer and immunoprecipitated 377	  
proteins eluted using IgG gentle elution buffer (Pierce) and analysed by SDS-378	  
PAGE. Large scale immunoprecipitations used 12 x T75 flasks and 2ml of 379	  
anti-myc resin.  380	  
Mass spectroscopy 381	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Proteins in gel bands were reduced with DTT and alkylated with 382	  
iodoacetamide before digestion with modified porcine trypsin 383	  
(Promega).  Digests were dissolved in 4-hydroxy-α-cyano-cinnamic acid and 384	  
analysed by positive-ion MALDI-MS/MS using a Bruker ultraflex III. Spectra 385	  
were submitted to Mascot MS/MS ions search against the NCBI database. 386	  
RhoA activity assays 387	  
Active RhoA in cell lysates was assessed by ELISA using a RhoA activity 388	  
assay (RhoA G-LISA; Cytoskeleton, Inc) as per the manufacturer’s 389	  
instructions. 390	  
Live cell imaging 391	  
NRK cells (WT) or expressing SseJ were transfected with either GFP-392	  
CLIP170 (kind gift of Folma Buss, University of Cambridge) or EB3-tdTomato 393	  
(a kind gift from Dr Anne Straube, University of Warwick) and 24 hours later 394	  
imaged on an Andor Spinning Disc Confocal Microscope. Images were 395	  
collected with 200ms exposures and a 800ms delay between exposures, 396	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Figure Legends 413	  
Figure 1. Expression of ssej causes CPY-Inv to be mis-sorted in 414	  
Saccharomyces cerevisiae. (A) Fragment of the Salmonella chromosome 415	  
inserted into the yeast expression vector causing CPY-Inv secretion. (B) 416	  
Qualitative CPY-Inv secretion in yeast expressing individual Salmonella genes 417	  
identified in (A). Negative control yeast (ctrl) contain just the cloning vector 418	  
(pVT-100U) and positive control yeast lack the receptor VPS10 for CPY 419	  
(∆VPS10). (C) Quantitative CPY-Inv secretion in yeast expressing Salmonella 420	  
genes. Controls as in (B). Data are from n=3-9 (number of experiments for 421	  
each condition in parentheses above each bar) and are mean ±  S.D. 422	  
*P<0.001 SseJ c.f. Ctrl (P>0.05 SseJ c.f. ∆VPS10). (D) Fluorescence 423	  
visualisation of the yeast vacuole in wild type yeast (WT) transformed with 424	  
vector (pVT-100U) alone or SseJ in pVT-100U (SseJ). Top panels DIC and 425	  
bottom panels FM 4-64 fluorescence. Scale bar = 10 µm. 426	  
Figure 2. Re-distribution of late endocytic organelles in cells expressing 427	  
SseJ. (A) NRK cells expressing myc-SseJ were double labelled with anti-myc 428	  
(a) and anti-lysosome glycoprotein 110 (Lgp110; b) followed by fluorescently 429	  
labelled secondary antibodies. Panel c is the merged image of panels a and b, 430	  
co-localisation is shown by yellow. (B) Control (Ctrl) NRK cells or NRK cells 431	  
expressing myc-SseJ (myc-SseJ) were immuno-labelled for the mannose 6-432	  
phosphate receptor (MPR), Lgp110 and trans-Golgi network 38 (TGN38) 433	  
followed by fluorescently-labelled secondary antibodies to visualise the late 434	  
endosomes, lysosomes and trans-Golgi network respectively. (C) Aggregation 435	  
of Lgp110 in NRK cells expressing SseJ for 24h (a). Quantification of cells 436	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showing aggregated lysosomes after induction of SseJ production with 437	  
cadmium (Cd) (b). Expression of myc-SseJ protein -/+ Cd is shown by the 438	  
western blot insert (b). (D) NRK cells were immunolabelled for microtubules 439	  
(α-tubulin; a,d), lysosomes (lgp120;b,e) and late endosomes (cation-440	  
independent mannose 6-phosphate receptor; c,f) in control cells (ctrl) or after 441	  
cells had been treated with 10µM nocodazole for 1h. Scale bars represent 442	  
10µm. 443	  
Figure 3. Microtubules are disrupted in cells expressing SseJ. (A) Control 444	  
(Ctrl) NRK cells and cells expressing myc-SseJ (SseJ) or myc-SseJ-S151A 445	  
(S151A) were fixed and the microtubules visualised using anti α-tubulin 446	  
antibodies and fluorescently-labelled secondary antibodies. Bars = 10µm. (B) 447	  
J774.2 mouse macrophages were either uninfected (Ctrl) or infected with WT 448	  
or ∆sseJ Salmonella Typhimurium for 24h before fixing. The DNA (blue) was 449	  
visualised using DAPI and the microtubules (red) were visualised as in A. 450	  
Bars = 20µm. Quantification of the number of cells showing an organised 451	  
microtubule network under each condition is shown (n=1, scoring 100 cells 452	  
per condition). (C) Cells as in A were fixed and de-tyrosinated α-tubulin (Glu-453	  
tubulin) visualised by immunolabelling using anti Glu-tubulin antibodies and 454	  
fluorescently-labelled secondary antibodies. Bars = 10µm. (D) Cells as in A 455	  
were lysed and lysates immunoblotted for acetylated-α−tubulin (Ac-tubulin) 456	  
and α-tubulin. (E) myc-SseJ production was induced in NRK cells up to 24h. 457	  
Lysates were generated and western blotted for myc-SseJ, acetylated-tubulin 458	  
and Rho (pan specific). (F) NRK cells (Ctrl) and those expressing sseJ (SseJ) 459	  
were transfected with a plasmid encoding EB3-tdTomato. EB3-tdTomato was 460	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visualised live, 24h later, on a spinning disc confocal microscope. Images 461	  
represent a single time frame. Bars = 10µm. 462	  
 463	  
Figure 4. SseJ binds GTPases RhoA and RhoC. (A) Anti-myc antibody was 464	  
covalently attached to sepharose and myc-SseJ was immunoprecipitated from 465	  
control (Ctrl) NRK cells or NRK cells expressing myc-SseJ (myc-SseJ). 466	  
Proteins bound to the beads were eluted and subjected to SDS-PAGE and 467	  
the gel stained with coomassie (shown). SseJ is indicated by an arrowhead. A 468	  
band at ≈21kDa specifically found in the SseJ immunoprecipitation was 469	  
excised and sequenced by mass spectroscopy and identified both RhoA and 470	  
RhoC. Peptides identified are shown by the insert with peptides common to 471	  
both RhoA and RhoC shown in bold, peptides unique to RhoA shown in blue 472	  
and peptides unique to RhoC shown by red. Only a single peptide was unique 473	  
to RhoC (highlighted by an asterisk). (B) Experiments as shown in A, 474	  
including cells expressing myc-SseJ(S151A), were repeated and western 475	  
blotted for myc, RhoA and RhoC. Western blots show 1/10th of the input 476	  
before and after the immunoprecipitation and the total eluate from the 477	  
immunoprecipitations.  (C) The activity of RhoA was measured by ELISA, on 478	  
extracts from control cells and cells expressing myc-SseJ or myc-SseJ 479	  
(S151A) mutant. Data are means ± SD, n=8. 480	  
 481	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